| P50 | author | Peter Uetz | Q13220218 |
| P2093 | author name string | Frank Schwarz | |
| | Gabriella Siszler | |
| | Sonja Blasche | |
| | Holger Steuber | |
| | Mario Mörtl | |
| | Michael S Donnenberg | |
| | Dirk Ullmann | |
| | Thomas M A Gronewold | |
| | Inna Lavrik | |
| | Klaus Maskos | |
| | Shahista Nisa | |
| | Manfred Kögl | |
| P2860 | cites work | Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. | Q52574553 |
| | Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006. | Q54454726 |
| | SAW Sensor System for Marker‐Free Molecular Interaction Analysis | Q58128030 |
| | The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology | Q82887079 |
| | Caspase-4 is required for activation of inflammasomes | Q83247309 |
| | Mechanism of XIAP-mediated inhibition of caspase-9 | Q24296916 |
| | Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death | Q24338605 |
| | Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. | Q24522487 |
| | DNA cloning using in vitro site-specific recombination | Q24622857 |
| | Improving the yeast two-hybrid system with permutated fusions proteins: the Varicella Zoster Virus interactome | Q24633667 |
| | MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 |
| | An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination | Q24678382 |
| | Dimer formation drives the activation of the cell death protease caspase 9 | Q27636617 |
| | XDS | Q27860472 |
| | One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 |
| | REFMAC5 for the refinement of macromolecular crystal structures | Q27860905 |
| | Phasercrystallographic software | Q27860930 |
| | Dali server: conservation mapping in 3D | Q27860994 |
| | Features and development of Coot | Q27861079 |
| | High-throughput mapping of a dynamic signaling network in mammalian cells | Q28239249 |
| | Caspase inhibitors: viral, cellular and chemical | Q28261303 |
| | Apoptosis: a review of programmed cell death | Q28305845 |
| | Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells. | Q30010247 |
| | Genes under positive selection in Escherichia coli. | Q30157906 |
| | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins | Q33209988 |
| | Fast, easy and efficient: site-specific insertion of transgenes into enterobacterial chromosomes using Tn7 without need for selection of the insertion event | Q33241518 |
| | The completion of the Mammalian Gene Collection (MGC). | Q33505160 |
| | NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection | Q33733678 |
| | Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM. | Q33773613 |
| | Decreased apoptosis in the ileum and ileal Peyer's patches: a feature after infection with rabbit enteropathogenic Escherichia coli O103. | Q34008363 |
| | Mutational analyses of the p35-caspase interaction. A bowstring kinetic model of caspase inhibition by p35. | Q34161691 |
| | XIAP discriminates between type I and type II FAS-induced apoptosis | Q34205704 |
| | Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway | Q34356501 |
| | Toxoplasma gondii inhibits granzyme B-mediated apoptosis by the inhibition of granzyme B function in host cells | Q35050044 |
| | Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis | Q35163164 |
| | The protein structures that shape caspase activity, specificity, activation and inhibition | Q35902423 |
| | Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. | Q37133792 |
| | The TRAIL apoptotic pathway in cancer onset, progression and therapy | Q37278043 |
| | Inhibition of programmed cell death by cytomegaloviruses | Q37802461 |
| | Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive | Q39488888 |
| | Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet. | Q39515881 |
| | Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili | Q39522797 |
| | Analysis of cis-acting elements required for bfpA expression in enteropathogenic Escherichia coli | Q39566388 |
| | Defining characteristics of Types I and II apoptotic cells in response to TRAIL. | Q41687820 |
| | FDA warns US consumers not to eat spinach after E coli outbreak | Q43255380 |
| | Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex. | Q46026102 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | e58937 | |
| P577 | publication date | 2013-03-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | The E. coli effector protein NleF is a caspase inhibitor | |
| P478 | volume | 8 | |